Molecules Are the New Microchips
Gene editing likely will change the world more profoundly than computer or nuclear technology, and with this life-science revolution comes investment opportunities as well as ethical conundrums.
Shifting Economy Could Bring New Market Winners
Quality stocks with a margin of safety can be found on the value side of most equity markets worldwide.
What’s the Deal? U.S.-China Trade Relations Remain Frosty
No skating around icy issues as America looks for signs that China wants to defrost trade differences.
Biological Innovations Revolutionizing Healthcare and Other Industries
CRISPR technologies hint at unfolding revolution as biology, data analytics and artificial intelligence intersect.
Inflation Still Driven by COVID-19 Effects, Not Runaway Demand
Current inflation bumps result of COVID-19’s lingering impact, not out-of-control demand as many pundits suggest.
GDP Growth in Q3 2021 Stumbled, but the Marathon Continues Into Q4
Key measures reflect a less vibrant third-quarter economic picture than many had hoped for.
There’s No Such Thing as Free Money
Proposed cuts to Biden’s $3.5 trillion Build Back Better plan might not really be cuts.
Is the U.S. Economy Heading Into Stagflation?
Rising prices and elevated unemployment conjure up the specter of 1970s-style stagflation.
Unicorns Flourish as Money Stampedes Into Market
No longer mythical, unicorn companies are attracting late-stage investors looking to saddle up and ride them to glittering heights.
Developing-Market Stocks Poised for Shot in Arm Next Year
Floundering emerging markets likely to start swimming in 2022 as vaccinations increase and China pulls them out of economic deep water.